FIELD: pharmaceuticals.
SUBSTANCE: invention relates to liquid medicines applied as a symptomatic (sedative and vasorelaxant) agent in functional disorders of the cardiovascular system, neurosis-like conditions associated with high irritability, sleep-onset insomnia, tachycardia, a state of excitation with pronounced vegetative manifestations, and as an antispasmodic agent in case of intestinal spasms. Agent contains motherwort herb infusion, phenobarbital, peppermint leaf oil, and excipients.
EFFECT: composition reduces the depressogenic effect of phenobarbital and prevents the accumulation of bromine in the body in prolonged or systematic intake with an associated increase in the overall sedative effect.
2 cl, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SEDATIVE MEDICINAL PRODUCT IN THE FORM OF TABLETS | 2021 |
|
RU2770037C1 |
| PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
| SEDATIVE DRUG AND METHOD OF MARJORAM ESSENTIAL OIL PREPARING FOR MEDICINAL AIMS | 2000 |
|
RU2157224C1 |
| SEDATIVE AND SPASMOLYTIC AGENT | 2014 |
|
RU2535019C1 |
| COMBINED PREPARATION POSSESSING SEDATIVE, SPASMOLYTIC AND ANTI-ALLERGIC EFFECT | 2004 |
|
RU2295968C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING SEDATIVE AND SPASMOLYTIC ACTION | 2014 |
|
RU2535020C1 |
| COMPLEX OF BIOLOGICALLY ACTIVE SUBSTANCES FOR EXPRESS RELAXATION | 2016 |
|
RU2682888C2 |
| SEDATIVE AND MUSCLE RELAXANT ACTION DRUG | 2019 |
|
RU2719376C1 |
| SOLID DRUG FORM OF MEDICATION WITH SEDATIVE AND ANTISPASMODIC EFFECT | 2013 |
|
RU2570374C2 |
| METHOD OF TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES WITH PHYTOPREPARATION AND MEDICINAL SPECIES FOR TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES | 2000 |
|
RU2163132C1 |
